Business
Currency:USD
2024/Q2
Stock NameRevenueRatio
Precision oncology testing166.52M93.95%
Development services and other10.72M6.05%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States526.52M93.36%
International37.42M6.64%